Adherence to interferon β treatment in Kosovan multiple sclerosis registry

Background. Because of side effects, adherence to the treatment with β interferons in multiple sclerosis (MS) is low, leading to decreased treatment efficacy. This can be challenging, especially in healthcare systems where these medications are the only therapeutic option for the treatment of MS. M...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Italian Journal of Medicine
المؤلفون الرئيسيون: Blerim Myftiu, Edmond Komoni, Edita Malazogu, Fisnik Jashari, Shpresa Beqiri Rashiti, Melihate Pushka, Adnan Biqku, Syzana Aliçkaj Prebreza, Valbona Rrahmani Spanca, Jehona Rrustemi Bytyqi, Nexhmedin Shala, Afrim Blyta
التنسيق: مقال
اللغة:الإنجليزية
منشور في: PAGEPress Publications 2024-01-01
الموضوعات:
β interferon
DMTs
multiple sclerosis
adherence rate
الوصول للمادة أونلاين:https://www.italjmed.org/index.php/ijm/article/view/1672

الانترنت

https://www.italjmed.org/index.php/ijm/article/view/1672

مواد مشابهة